Tony Yu

Role: Senior Vice President, Clinical Development at Genelux
Location: San Diego, CA, US
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

About Tony Yu

A. Clinical Operations and Research Development of Cancer Drugs: 23 years in biotech/…

Experience

Senior Vice President, Clinical Development
Genelux
Apr 2023 — Present

Skills

Oncolytic Virus
Clinical Development
Oncology
Human Anatomy
Life Sciences
Preclinical Research
Biologics
Molecular Biology
R&D
Clinical Research
Optical Imaging
Laboratory
Biotechnology
Cancer Research
Clinical Trials
Pharmaceutical Industry
Animal Models
Biopharmaceuticals
Toxicology
In Vivo
Cancer
Drug Discovery

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
t•••@genelux.com
Personal email
•••••@•••••.com
Direct dial
+15•••••••57

Unlock verified contacts

Free to start · No credit card required

Current company

Genelux

Biotechnology Research · 34 employees · Founded 2001 · Westlake Village, California, United States

Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology company focused on improving the lives of patients affected by difficult-to-treat solid tumors. Our ChoiceTM Discovery Platform is the foundation of our oncolytic immunotherapy development, having produced over 500 different versions of the vaccinia virus. Olvi-Vec, our lead product candidate is currently in a Phase 3 registrational clinical trial for Platinum-Resistant/Refractory Ovarian Cancer (PRROC). Olvi-Vec is also being developed in Non-Small Cell Lung Cancer (NSCLC), recurrent Small Cell Lung Cancer (SCLC), and recurrent Ovarian Cancer. We are dedicated to advancing a pipeline of next-generation oncolytic immunotherapies that deliver the full complement of tumor neo-antigens with the power to stimulate a personalized immune response for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Information about our investigational products and clinical trials can be found here. For more information, please visit https://genelux.com/ and follow us on Twitter @Genelux_Corp and Facebook @Genelux. Olvi-Vec is an investigational product candidate not yet approved by the US Food and Drug Administration.

genelux.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Tony Yu

Experience

Senior Vice President, Clinical Development

Skills

Find verified contacts for anyone on LinkedIn